Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.10.0.1
Consolidated Statements of Operations - USD ($)
3 Months Ended
Aug. 31, 2018
Aug. 31, 2017
Operating expenses:    
General and administrative $ 1,996,428 $ 1,569,680
Research and development 11,403,294 8,148,175
Amortization and depreciation 88,971 89,146
Total operating expenses 13,488,693 9,807,001
Operating loss (13,488,693) (9,807,001)
Interest income 979 787
Change in fair value of derivative liability (747,467) (362,666)
Interest expense:    
Amortization of discount on convertible notes (64,580) (444,152)
Amortization of debt issuance costs (9,178) (113,700)
Inducement interest related to warrant exercise   (826,252)
Interest on convertible notes payable (104,630) (75,289)
Total interest expense (178,388) (1,459,393)
Loss before income taxes (14,413,569) (11,628,273)
Provision for taxes on income 0 0
Net loss $ (14,413,569) $ (11,628,273)
Basic and diluted loss per share $ (0.07) $ (0.08)
Basic and diluted weighted average common shares outstanding 218,594,628 151,738,244